Locust Walk Sponsor, LLC 4
4 · eFFECTOR Therapeutics, Inc. · Filed Aug 27, 2021
Insider Transaction Report
Form 4
Locust Walk Sponsor, LLC
10% Owner
Transactions
- Conversion
Common Stock
[F1]2021-08-25+3,511,250→ 4,056,250 total - Disposition to Issuer
Class B Common Stock
[F1][F2]2021-08-25−1,000,000→ 3,511,250 total→ Common Stock (1,000,000 underlying) - Conversion
Class B Common Stock
[F1]2021-08-25−3,511,250→ 0 total→ Common Stock (3,511,250 underlying)
Footnotes (2)
- [F1]On August 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of May 26, 2021 (the "Merger Agreement"), by and among the Issuer (f/k/a Locust Walk Acquisition Corp.), Locust Walk Merger Sub, Inc. ("Merger Sub"), and eFFECTOR Therapeutics, Inc. ("Old eFFECTOR"), Merger Sub merged with and into Old eFFECTOR with Old eFFECTOR surviving as a wholly owned subsidiary of the Issuer (the "Merger"). In connection with and upon consummation of the Merger, each of the Issuer's outstanding shares of Class B Common Stock automatically converted into one share of Class A Common Stock and such shares of Class A Common Stock were automatically reclassified in shares of common stock.
- [F2]Pursuant to an agreement by and between the Issuer and the reporting person, concurrent with the consummation of the Merger, these shares of Class B Common Stock were forfeited to the Issuer immediately prior to the Merger.
Signature
/s/ Chris Ehrlich, Chief Executive Officer|2021-08-27